Emerging therapeutic targets in oncology: urokinase-type plasminogen activator system
- 1 March 1999
- journal article
- Published by Informa Healthcare in Emerging Therapeutic Targets
- Vol. 3 (1) , 109-133
- https://doi.org/10.1517/14728222.3.1.109
Abstract
No abstract availableThis publication has 94 references indexed in Scilit:
- On the size of the active site in proteases. I. PapainPublished by Elsevier ,2005
- Requirement of Receptor-bound Urokinase-type Plasminogen Activator for Integrin αvβ5-directed Cell MigrationJournal of Biological Chemistry, 1996
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- The 2.3 Å Crystal Structure of the Catalytic Domain of Recombinant Two-chain Human Tissue-type Plasminogen ActivatorJournal of Molecular Biology, 1996
- Significance of angiogenesis in tumour progression and metastasisEuropean Journal Of Cancer, 1995
- Inhibition of metastasis of lewis lung carcinoma by a synthetic peptide within growth factor‐like domain of urokinase in the experimental and spontaneous metastasis modelInternational Journal of Cancer, 1994
- Solution Structure of the Kringle Domain from Urokinase-type Plasminogen ActivatorJournal of Molecular Biology, 1994
- A cyclopeptidic suicide substrate preferentially inactivates urokinase-type plasminogen activatorBiochemical and Biophysical Research Communications, 1991
- Substrate specificity of tissue-type and urokinase-type plasminogen activatorsBiochemical and Biophysical Research Communications, 1991
- Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells.The Journal of cell biology, 1987